Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan prophylaxis for episodic cluster headache
2004-004999-36Phase 3Terminated
- Sponsor
- Berlin-Chemie AG
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cluster Headache (CH) comparing Frovatriptan with Placebo (2 arms). Primary endpoint: Mean cluster headache attack frequency per week during the two weeks treatment period. Started Aug 2006; status: terminated.
02
Drugs
frovatriptan
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2004-004999-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004999-36.